Convalescent Plasma Is Hardly A “Breakthrough”
The data for convalescent plasma is not good
On August 23, the FDA issued an emergency use authorization for convalescent plasma for the treatment of severe COVID-19. The Trump Administration hailed convalescent plasma as a “breakthrough” treatment for COVID-19. That is a bit of a stretch.